This page is under construction. It is intended to track all pharmaceutical partnership related activities starting on July 7.
***7/11 BDSI licensing agreement with Purdue Pharma
BioDelivery Sciences (BDSI) Enters Agreement With Purdue Pharma (Canada) For Licensing And Distribution Rights Of BELBUCA
***7/11 ABZA licensing agreement with OBI
Abzena and OBI Pharma Sign ThioBridge™ Licence Agreement
***7/11 cytovia (IMNP oncology subsidiary) licensing agreement with Pint Pharma
Immune Pharma (IMNP) Subsidiary Enters into Definitive Agreement with Pint Pharma for Licensing and Commercialization of Ceplene in Latin America
*** 7/10 CAPR DMD focused clinical stage company has ended partnership with JnJ/Janssen
J&J did not exercise option on Capricor Stem Cell Partnership
* ** 7/10 OPHT: Licensing agreement halt
Novartis hits pause on Fovista agreement
Due to lack of effectiveness shown so far for treatment of anti PDGF in wet amd.
***Zealand Pharma: Helsinn Healthcare 7/6/2017
License Agreement Between Zealand Pharma a/S and Helsinn Healthcare Sa
***CNAT: Novartis : 7/7/2017